Recall MonitorHealth ProductsType I recall
Octreotide for injectable suspension; Good manufacturing practices concerns
· Published by Health Canada · Official notice
Details
Alert type: Health product recall
Category: Health products - Drugs
Product: Octreotide for injectable suspension
Issue: Health products - Product quality
What to do: If you have an affected product, do not use it. Speak to your health care professional immediately to obtain an alternative or replacement product. Seek medical attention if you have used this product and are experiencing symptoms of infection, or other unexpected symptoms or side effects.
Audience: General public, Healthcare, Industry
Recall class: Type I
Products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot Number |
|---|---|---|---|---|---|
| Teva Canada Ltd. | Octreotide for injectable suspension 10 mg/vial | DIN 02503751 | Kit, Powder For Suspension, Sustained-Release | Octreotide acetate 10 mg/vial | 4401203R, 4401202, 4400915 |
| Teva Canada Ltd. | Octreotide for injectable suspension 20 mg/vial | DIN 02503778 | Kit, Powder For Suspension, Sustained-Release | Octreotide acetate 20 mg/vial | 4501460, 4401309, 4401501, 4401231, 4401065 |
| Teva Canada Ltd. | Octreotide for injectable suspension 30 mg/vial | DIN 02503786 | Kit, Powder For Suspension, Sustained-Release | Octreotide acetate 30 mg/vial | 4501296, 4401394, 4500804, 4500219, 4401208, 4500218, 4401207, 4400955, 4400918 |
Issue
Quality concerns of affected lots due to deficiencies in Good Manufacturing Practices (GMP).